RESUMEN
CLINICAL CASE: The case is presented of 37 year-old male with a history of nasal obstruction with right rhinorrhea, headache, hearing loss and right exophthalmos of 4 months progression. The MRI revealed that the ethmoidal and maxillary sinuses contained inflammatory tissue extending into the orbital region. The biopsy confirmed a non-Hodgkin lymphoma of natural killer (NK) T cells. DISCUSSION: Non-Hodgkin's T NK lymphoma is a rare tumor in the orbital area that requires an early detection and multi-disciplinary care to ensure appropriate monitoring and treatment.
Asunto(s)
Senos Etmoidales/patología , Linfoma Extranodal de Células NK-T/patología , Seno Maxilar/patología , Órbita/patología , Adulto , Protocolos de Quimioterapia Combinada Antineoplásica/administración & dosificación , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Biopsia , Médula Ósea/patología , Cisplatino/administración & dosificación , Citarabina/administración & dosificación , Senos Etmoidales/diagnóstico por imagen , Etopósido/administración & dosificación , Exoftalmia/etiología , Resultado Fatal , Humanos , Linfoma Extranodal de Células NK-T/complicaciones , Linfoma Extranodal de Células NK-T/diagnóstico por imagen , Linfoma Extranodal de Células NK-T/tratamiento farmacológico , Masculino , Seno Maxilar/diagnóstico por imagen , Metilprednisolona/administración & dosificación , Obstrucción Nasal/etiología , Recurrencia Local de Neoplasia , Órbita/diagnóstico por imagen , Terapia Recuperativa , Tomografía Computarizada por Rayos XRESUMEN
Synovial cysts of the temporomandibular joint (TMJ) are very rare, and to date, only 12 cases of a synovial cyst in the TMJ region have been reported in the literature. In this paper, we present the clinicopathological and immunohistochemical characteristics of one such lesion affecting a 48-year-old woman, presented with a mass in the left preauricular region. We describe the usefulness of immunohistochemical analysis for recognizing the synovial lining, which allowed for clear differentiation between ganglion and synovial cysts. Immunohistochemical analyses can be used to diagnose synovial cysts with certainty; however, using at least two markers is advisable to distinguish the two existing synovial cell subtypes. Our findings indicate that synovial cysts of TMJ possess an internal lining dominated by type B (fibroblast-like) synoviocytes.
RESUMEN
The identification of HER2 alterations in advanced gastric carcinomas is of critical importance in daily clinical practice as such neoplasms require specific treatment with trastuzumab. For these reasons, pathologists and oncologists with expertise in gastric carcinomas and HER2 testing from both organisations (SEAP and SEOM) have endeavoured to discuss and agree on national guidelines for HER2 testing in gastric carcinomas. These guidelines are based on the experience of those who participated in the discussions and also on experience published internationally. These agreed guidelines give the minimum requirements that a pathological anatomy laboratory must fulfil in order to guarantee adequate HER2 testing in daily practice. Any laboratories which do not meet the minimum standards set out in the guidelines must make every effort to achieve compliance (AU)
Asunto(s)
Humanos , Masculino , Femenino , Consenso , Genes erbB-2/genética , Pruebas Genéticas/métodos , Pruebas Genéticas , Guías de Práctica Clínica como Asunto , Neoplasias Gástricas/genética , Oncología Médica/legislación & jurisprudencia , Oncología Médica/métodos , Oncología Médica/organización & administración , Patología Molecular/legislación & jurisprudencia , Patología Molecular/métodos , Patología Molecular/organización & administración , Sociedades Médicas/legislación & jurisprudencia , Neoplasias Gástricas/diagnóstico , Neoplasias Gástricas/patología , Biomarcadores de Tumor/genéticaRESUMEN
The case is presented of a 10-year-old HIV+ male with renoureteral pain, who developed an obstructive uropathy with renal function impairment and required endoscopic placement of a ureteral stent. Certain aspects of the epidemiology, clinical presentation, diagnosis, treatment and prevention are discussed.
RESUMEN
UNLABELLED: BK virus (BKV) reactivation in immunocompromised kidney transplant patients can produce a tubulointerstitial nephropathy (BKVN). Molecular tools that test for DNA-BKV provide early detection and assist in management, but some aspects of the pathogenesis of this infection, such as donor causality, remain unclear. MATERIALS AND METHODS: Between November 2004 and January 2006, 55 Spanish kidney donors were studied for BK infection. A quantitative PCR assay was performed on urine and serum to detect BKV. To determine the origin of the viral infection, a transcription control region of the BK polymorphism sequence was designed to identify the viral subtype. RESULTS: Fifteen of 55 (27%) donors were BK-PCR positive: 13 in urine and 2 in serum and urine. Moreover, monitoring of recipient pairs detected BK-PCR positivity in 14 of 73 recipients. We studied eight BK-PCR positive recipients (corresponding to four pairs) and their respective donors. The same viral genome was observed in the four pairs, namely, the A250-1-a, WW-like, AS, and JL genotypes. Interestingly, one of the four pairs showed the donor and the two recipients to display exactly the same JL genotype. CONCLUSION: On the basis of our preliminary results analyzing the molecular fingerprints of donor and recipient pairs, we have presented new data implicating the donor, in at least some cases, as the source of BK infection.
Asunto(s)
Virus BK/aislamiento & purificación , Riñón/virología , Infecciones por Polyomavirus/transmisión , Virus BK/clasificación , Virus BK/genética , Genoma Viral , Humanos , Reacción en Cadena de la Polimerasa , España , Donantes de TejidosRESUMEN
Small cell carcinoma of the bladder is a rare entity characterized by an aggressive clinical behaviour with a high incidence of systemic metastases. We report a case of small cell carcinoma of the bladder in a young man. The primary local tumour was treated by radical surgery, pelvic radiation therapy and polychemotherapy according CDDP protocol. The patient died six months after surgery because disease progression. We also review and update the literature concerning this infrequently tumour.
Asunto(s)
Carcinoma de Células Pequeñas/diagnóstico , Neoplasias de la Vejiga Urinaria/diagnóstico , Adulto , Humanos , MasculinoRESUMEN
INTRODUCTION AND OBJECTIVE: Vesical tumor T1G3 constitutes the border between the superficial tumor and the infiltrante tumor. Some of these tumors do not respond to BCG and progress, with cystectomy that present poor results, patients who would benefit from a precocious and aggressive treatment if we could identify them in an preinvasive stage. New predictive factors try to select to these tumors, being little the works that consider anatomo-pathological meticulous study (substanding of the T1 in T1a and T1b and percentage of present G3 cells in the tumor). Our objective is to analyze the value of these anatomo-pathological considerations like predictive factors of progression. MATERIAL AND METHODS: Retrospective study of a series of 91 patient affection of vesical tumor T1G3 with initial treatment by means of RTU and BCG. We analyzed 12 variables. The new predictive factors: the level of invasion respect to muscularis mucosae and the percentage of G3 cells. By means of logistic regression analisys we establish the independent pronostic factors for tumoral progression. RESULTS: A total of 31 patients presented infiltration of detrusor, passing away 17 of tumoral cause, after an average time of pursuit of 57.8 +/- 28.2 months. In 8 cases (9%) the substanding could not be determined. The rate of progression for T1a tumors was of 20% (8/40) and for T1b 53% (23/43). Presented independent predictive value of progression the multiplicity (odds: 7.26), the size (odds: 2.14), the presence of Cis (odds: 1.42) and the subestanding (odds: 6.81). CONCLUSION: The substanding is a predictive factor of progression clinically useful in vesical tumors T1G3, reason why we considered habitual clinical introduction.
Asunto(s)
Neoplasias de la Vejiga Urinaria/patología , Anciano , Femenino , Humanos , Masculino , Estadificación de Neoplasias , Valor Predictivo de las Pruebas , Estudios Retrospectivos , Vejiga Urinaria/patologíaRESUMEN
INTRODUCTION AND OBJECTIVE: Bladder tumor T1G3 constitutes the group of superficial tumors more aggressive. New prognostic factors in the field of the cytogenetics and molecular biology have been analyzed, with often contradictory results, being little the specific works in tumors T1G3. Our objective is to determine if in this group of tumors the immunohistochemical markers present predictive value of clinically useful progression, and therefore with validity to indicate more suitable a precocious therapeutic attitude. MATERIAL AND METHODS: Retrospective study of a series of 83 patients affected of bladder tumor T1G3, on which we analyzed a total of 14 variables; between the new predictive factors: the immunohistochemical determination of regulating proteins of the cellular cycle: p53, p21 and bcl-2, as well as the Ki-67 protein like marker of cellular proliferation. By means of logistic regression analysis we establish the independent prognostic variables for tumorlike progression. RESULTS: The cut point established for Ki67 and p53 was 40% of inmmunomarked cells, 20% for p21 and 10% for Bcl-2. The univariant analysis showed different rates from progression and free times of progression based on the immunohistochemistry of Ki67 and p53: nevertheless, the logistic regression demonstrated that single the immunohistochemistry of p53 presented independent predictive value. CONCLUSIONS: The determination of p53 presents predictive value of clinically useful progression in bledder tumors T1G3, so that its determination can constitute a essential factor in the strategies of treatment of these tumors.
Asunto(s)
Proteínas de Ciclo Celular/análisis , Neoplasias de la Vejiga Urinaria/química , Neoplasias de la Vejiga Urinaria/patología , Femenino , Humanos , Inmunohistoquímica , Masculino , Estadificación de Neoplasias , Estudios RetrospectivosRESUMEN
INTRODUCTION: Ameloblastomas are the most frequent odontogenic tumors of the maxilla. In spite of their benign cytohistological appearance, they behave as invasive recurring tumors, with the possibility of metastasis. FNAB is a rapid, bloodless test that provides a pre-surgical diagnosis, thus, on occasions avoiding the need for diagnostic biopsies. We present the cytological characteristics of two cases of jugal recurrences of mandibular ameloblastomas diagnosed by FNAB, as well as their cytohistological correlation. CLINICAL CASES: Two patients, a 36-year-old woman, and a 62-year-old male who both attended with mandibular swelling of a few months evolution. In both cases the first diagnostic approximation was the histological study of the tumoral mass, together with the radiological studies. Following therapeutic extirpation both cases recurred. The diagnosis of the recurrences was established cytologically by means of FNAB. The cytologic smears revealed a granular background with isolated macrophages and giant multinucleate cells and an abundant epithelial cellularity of basaloid appearance arranged in cohesive groups forming images of peripheral palidasing, as well as small groups of squamous metaplastic cells. DISCUSSION: FNAB is considered to be a rapid, bloodless and reliable method for the diagnosis of ameloblastoma. The cytology of these tumors reveals components of the lesion that, in general, are sufficient for the diagnosis of ameloblastoma, especially in cases of recurrence.
Asunto(s)
Ameloblastoma/patología , Neoplasias Mandibulares/patología , Adulto , Biopsia con Aguja Fina , Diagnóstico Diferencial , Femenino , Humanos , Masculino , Persona de Mediana Edad , Recurrencia Local de Neoplasia/diagnósticoRESUMEN
Introducción y Objetivos: El tumor vesical T1G3 constituye la frontera entre el 'tumor superficial' y el 'tumor infiltrante'. Algunos de estos tumores no responden a BCG y progresan, con cistectomías que presentan pobres resultados, pacientes que se beneficiarían de un tratamiento precoz mas agresivo si pudiéramos identificarlos en una etapa preinvasiva. Nuevos factores predictivos intentan seleccionar estos tumores, siendo escasos los trabajos que consideran un estudio anatomopatológico mas minucioso (subestadiaje del T1 en T1a y T1b y porcentaje de células G3 presentes en el tumor). Nuestro objetivo es analizar el valor de estas consideraciones anatomo-patológicas como factores predictivos de progresión. Material y Métodos: Estudio retrospectivo de una serie de 91 pacientes afectos de tumor vesical T1G3 sometidos a tratamiento inicial mediante RTU e instilaciones de BCG. Analizamos 12 variables; entre los nuevos factores predictivos: el nivel de invasión respecto de la muscularis mucosae y el porcentaje de células G3. Mediante análisis de regresión logística establecemos las variables pronósticas independientes para progresión tumoral. Resultados: Un total de 31 pacientes presentaron infiltración del detrusor, falleciendo 17 de causa tumoral, tras un tiempo medio de seguimiento de 57,8 ± 28,2 meses. En 8 casos (9%) no se pudo determinar el subestadiaje. La tasa de progresión para tumores T1a fue del 20% (8/40) y para T1b 53% (23/43). Presentaron valor predictivo independiente de progresión la multiplicidad (odds: 7,26), el tamaño (odds: 2,14), la presencia de Cis (odds:1,42) y el subestadiaje (odds: 6,81). Conclusión: El subestadiaje es un factor predictivo de progresión clínicamente útil en tumores vesicales T1G3,por lo que consideramos fundamental su introducción en la práctica clínica habitual (AU)
Introduction and objective: Vesical tumor T1G3 constitutes the border between the superficial tumor and the infiltrante tumor. Some of these tumors do not respond to BCG and progress, with cystectomy that present poor results, patients who would benefit from a precocious and aggressive treatment if we could identify them in an preinvasive stage. New predictive factors try to select to these tumors, being little the works that consider anatomo- pathological meticulous study (substanding of the T1 in T1a and T1b and percentage of present G3 cells in the tumor). Our objective is to analyze the value of these anatomo-pathological considerations like predictive factors of progression. Material and methods: Retrospective study of a series of 91 patient affection of vesical tumor T1G3 with initial treatment by means of RTU and BCG. We analyzed 12 variables. The new predictive factors: the level of invasion respect to muscularis mucosae and the percentage of G3 cells. By means of logistic regression analisys we establish the independent pronostic factors for tumoral progression. Results: A total of 31 patients presented infiltration of detrusor, passing away 17 of tumoral cause, after an average time of pursuit of 57.8 ± 28.2 months. In 8 cases (9%) the substanding could not be determined. The rate of progression for T1a tumors was of 20% (8/40) and for T1b 53% (23/43). Presented independent predictive value of progression the multiplicity (odds: 7,26), the size (odds: 2,14), the presence of Cis (odds: 1,42) and the subestanding (odds: 6,81). Conclusion: The substanding is a predictive factor of progression clinically useful in vesical tumors T1G3, reason why we considered habitual clinical introduction (AU)
Asunto(s)
Humanos , Neoplasias de la Vejiga Urinaria/patología , Estudios Retrospectivos , Vacuna BCG/uso terapéutico , Cistectomía , Biomarcadores de Tumor/análisis , Estadificación de Neoplasias , Neoplasias de la Vejiga Urinaria/clasificación , Neoplasias de la Vejiga Urinaria/terapiaRESUMEN
BACKGROUND: The aim of this study was to investigate new prognostic factors, by using a prognostic model, that could help to identify the patient group with the greatest probability of death. PATIENTS AND METHODS: First, the clinicopathological variables were analyzed. Second, microvessels were immunohistochemically (IHC) stained with factor VIII-related antibody and then counted in the most intense vascularization area or hotspot, using an automatic image analyzer. In addition, biological angiogenesis-related factors such as vascular endothelial growth factor (VEGF) and inducible nitric oxide synthase expression (iNOS) were also studied. Finally, we evaluated the IHC expression of p53 and p21WAF1 tumor supressor proteins. RESULTS: The significant independent predictors were: tumor size (p=0.0063), angiogenesis (p=0.0271) and p21WAF1 (p=0.0478). Thus, the most important factor was tumor size 2.7462 [95% CI=1.3307-5.6673]. Finally, these variables were included in a risk model, in order to identify the group with the highest associated probability of death. CONCLUSION: The analysis of several prognostic factors could establish a more accurate patient risk profile.
Asunto(s)
Carcinoma de Pulmón de Células no Pequeñas/diagnóstico , Carcinoma de Pulmón de Células no Pequeñas/metabolismo , Neoplasias Pulmonares/diagnóstico , Neoplasias Pulmonares/metabolismo , Neovascularización Patológica , Anciano , Proteínas de Ciclo Celular/metabolismo , Inhibidor p21 de las Quinasas Dependientes de la Ciclina , Factor VIII/metabolismo , Femenino , Humanos , Procesamiento de Imagen Asistido por Computador , Inmunohistoquímica , Masculino , Persona de Mediana Edad , Modelos Teóricos , Análisis Multivariante , Neoplasias/metabolismo , Óxido Nítrico Sintasa/metabolismo , Óxido Nítrico Sintasa de Tipo II , Pronóstico , Riesgo , Factores de Tiempo , Proteína p53 Supresora de Tumor/metabolismo , Factor A de Crecimiento Endotelial Vascular/metabolismoRESUMEN
Introducción y Objetivos: El tumor vesical T1G3 constituye el grupo de tumores superficiales más agresivo. Nuevos factores pronósticos en el campo de la citogenética y la biología molecular han sido analizados, con resultados a menudo contradictorios, siendo escasos los trabajos específicos en tumores T1G3. Nuestro objetivo es determinar si en este grupo de tumores los marcadores inmunohistoquímicos presentan valor predictivo de progresión clínicamente útil, y por tanto con validez para indicar una actitud terapéutica precoz más idónea. Material y Métodos: Estudio retrospectivo de una serie de 83 pacientes afectos de tumor vesical T1G3, sobre los que analizamos un total de 14 variables; entre los nuevos factores predictivos: la determinación inmunohistoquímica de las proteínas reguladoras del ciclo celular: p53, p21 y bcl-2, así como la proteína Ki-67 como marcador de proliferación celular. Mediante análisis de regresión logística establecemos las variables pronósticas independientes para progresión tumoral. Resultados: El punto de corte establecido para Ki67 y p53 fue el 40% de células inmunomarcadas, 20% para p21 y10% para Bcl-2. El análisis univariante puso de manifiesto diferentes tasas de progresión y tiempos libres de progresión en función de la inmunotinción de Ki67 y p53; sin embargo, la regresión logística demostró que solo la inmunohistoquímica de p53 presentaba valor predictivo independiente. Conclusiones: La determinación inmunohistoquímica de p53 presenta valor predictivo de progresión clínicamente útil en tumores vesicales T1G3, de manera que su determinación puede constituir un factor fundamental en las estrategias de tratamiento de estos tumores (AU)
Introduction and objective: Bladder tumor T1G3 constitutes the group of superficial tumors more aggressive. New prognostic factors in the field of the cytogenetics and molecular biology have been analyzed, with often contradictory results, being little the specific works in tumors T1G3. Our objective is to determine if in this group of tumors the immunohistochemical markers present predictive value of clinically useful progression, and therefore with validity to indicate more suitable a precocious therapeutic attitude. Material and methods: Retrospective study of a series of 83 patients affected of bladder tumor T1G3, on which we analyzed a total of 14 variables; between the new predictive factors: the immunohistochemical determination of regulating proteins of the cellular cycle: p53, p21 and bcl-2, as well as the Ki-67 protein like marker of cellular proliferation. By means of logistic regression analisys we establish the independent prognostic variables for tumor like progression. Results: The cut point established for Ki67 and p53 was 40% of inmmunomarked cells, 20% for p21 and 10% forBcl-2. The univariant analysis showed different rates from progression and free times of progression based on the immunohistochemistry of Ki67 and p53; nevertheless, the logistic regression demonstrated that single the immunohistochemistry of p53 presented independent predictive value. Conclusions: The determination of p53 presents predictive value of clinically useful progression in bledder tumorsT1G3, so that its determination can constitute a essential factor in the strategies of treatment of these tumors (AU)
Asunto(s)
Humanos , Proteínas de Ciclo Celular/análisis , Neoplasias de la Vejiga Urinaria/patología , Ciclo Celular/fisiología , Pronóstico , Biomarcadores de Tumor/análisis , Estudios Retrospectivos , Inmunohistoquímica/métodos , Proteína p53 Supresora de Tumor/análisisRESUMEN
INTRODUCTION: Reactivation of BK infection occurs in immunocompromised hosts causing tubulointerstitial nephropathy (BKVN). Approximately 5% of kidney transplant recipients (KTR) develop BKVN, special half of whom lose their grafts. However, BKVN morphologic diagnosis on a renal biopsy is complicated, because the cytopathic changes can sometimes mimic rejection. Thus, BKV DNA-polymerase chain reaction (PCR) assay on serum, urine, and renal tissue is useful for early detection and monitoring of BKV. MATERIALS AND METHODS: We performed routine monthly urine cytologies looking for decoy cells as a marker of virus replication. Then, we performed a qualitative PCR on urine and serum in all recipients (independently of positive or negative cytology). We amplified 3 BK viral genome regions, LT (early transcription region) and VP1 (late transcription region) seeking a more accurate virus detection, and the TCR (control transcription region) region to perform a polymorphism sequence analysis to identify the BK genomic variant. Finally, the BKVN diagnosis was confirmed using renal biopsy. RESULTS: At present, 132 patients have been monitored. Thirteen of 40 (33%) were PCR-urine-positive cases (5 LT+/VP1- and 8 LT+/VP1+), and 10 of 132 (7.5%) were PCR-serum-positive cases (7 LT+/VP1- and 3 LT+/VP1+). When we compared PCR-urine and cytology results, 11 of 40 (27.5%) patients showed a positive cytology, 6 of whom were PCR- urine-positive (1 LT+/VP1- and 5 LT+/VP1+); whereas, 29 patients showed a negative cytology, 7 of whom were PCR-urine-positive(3 LT+/VP1- and 4 LT+/VP1+). Thus, comparison of PCR- urine and cytology results revealed false-positive and false-negative cases. Finally, TCR sequence analysis was performed in 9 patients to identify the BK genomic variants. CONCLUSION: Testing for BKV DNA in urine and serum is a noninvasive early detection assay and monitoring tool.
Asunto(s)
Virus BK/genética , Virus BK/aislamiento & purificación , Trasplante de Riñón/patología , Infecciones por Polyomavirus/diagnóstico , Complicaciones Posoperatorias/virología , Infecciones Tumorales por Virus/diagnóstico , Adulto , Niño , ADN Viral/sangre , ADN Viral/aislamiento & purificación , ADN Viral/orina , Femenino , Hospitales Universitarios , Humanos , Masculino , Persona de Mediana Edad , Monitoreo Fisiológico , Reacción en Cadena de la Polimerasa/métodos , Complicaciones Posoperatorias/diagnóstico , EspañaRESUMEN
INTRODUCTION AND OBJECTIVES: Angiogenic activity has been considered like prognostic factor in several solid tumors. This activity can be analysed by two ways: immunohistochemical determination of molecules that activate/inhibit angiogenesis or quantitive measure of microvascular density (MD). Our objective is to determine the prognostic value of Vascular Endothelial Growth Factor (VEGF) and Microvascular Density (MD) in pT1G3 bladder tumours. MATERIAL AND METHODS: We have studied retrospectively 83 patients with pT1G3 tumors treated by TUR + endovesical instillations with a follow up of 3 years at least. We analysed VEGF expression monoclonal antibody No. 360P. To determine MD we have marked vessels with FVIII antibody and detected "hot spots" areas. The number of microvessels is quantited by a digital image analyser excluding those that have more than 50 micras of diameter. We established the correlation of these findings with recurrence, progression and survival by using Chi-square test and Kaplan-Meier curves (log-rank). RESULTS: Average follow up was 58 +/- 28 months. We have established like cut-off 50% of tumor cells (VEGF) and 30 microvessels/fields (MD). Chi-square test did not show correlation with survival neither recurrence but it was positive for progression p(VEGF) 0.048 and p(DM) 0.021. Kaplan Meier curves determined significative differences only for free of progression time respect to MD (p 0.038). CONCLUSIONS: We did not find statistically significant value for recurrence nor survival. Just MD reached prognostic value for progression. More studies and multivariant analysis are required to determine the clinical utility of MD, specially in order to make more aggressive therapeutic options in this kind of patients.
Asunto(s)
Neovascularización Patológica , Neoplasias de la Vejiga Urinaria/irrigación sanguínea , Neoplasias de la Vejiga Urinaria/patología , Estudios de Seguimiento , Humanos , Estadificación de Neoplasias , Pronóstico , Estudios Retrospectivos , Programas Informáticos , Neoplasias de la Vejiga Urinaria/química , Factores de Crecimiento Endotelial Vascular/análisisRESUMEN
The case of a 5 months old infant with a nephrotic syndrome after neonatal cytomegalovirus infection is reported. Genomic amplification nested-PCR for CMV was positive in renal biopsy. Treatment with gancyclovir was effective to maintain nephrotic syndrome remission. We stresses the importance to discharge an infections cause of the nephrotic syndrome of newborns and infants due to the possibility on curative treatment.
Asunto(s)
Infecciones por Citomegalovirus/virología , Síndrome Nefrótico/virología , Anticuerpos Antivirales/análisis , Antivirales/uso terapéutico , Infecciones por Citomegalovirus/tratamiento farmacológico , Infecciones por Citomegalovirus/patología , Ganciclovir/uso terapéutico , Humanos , Lactante , Riñón/patología , Masculino , Síndrome Nefrótico/tratamiento farmacológico , Síndrome Nefrótico/patología , Resultado del TratamientoRESUMEN
Epidermoid cysts of the testis are rare in children (3% of all the testicular tumors). Bilateral appearance has only been described in the pediatric age in 2 cases and none associated to Klinefelter's syndrome. We present, for our knowledge, the first case of bilateral epidermoid testicular cyst associated to klinefelter's syndrome in a boy, highlighting its management and therapeutic approach. We analyze the different kinds of treatment.
Asunto(s)
Quiste Epidérmico/complicaciones , Síndrome de Klinefelter/complicaciones , Enfermedades Testiculares/complicaciones , Preescolar , Quiste Epidérmico/diagnóstico , Quiste Epidérmico/terapia , Humanos , Masculino , Enfermedades Testiculares/diagnóstico , Enfermedades Testiculares/terapiaRESUMEN
Los quistes epidérmicos testiculares son lesiones muy infrecuentes en la edad infantil (3 por ciento de todas las tumoraciones testiculares). Sólo se ha descrito su aparición bilateral en la edad pediátrica en 2 observaciones y ninguna de ellas asociada a síndrome de Klinefelter. Presentamos, en este sentido, el primer caso en nuestro conocimiento de quiste epidérmico bilateral testicular asociado a síndrome de Klinefelter en un niño, destacando el manejo y la conducta terapéutica realizada analizando asimismo las distintas pautas de tratamiento propuestas (AU)
Asunto(s)
Preescolar , Masculino , Humanos , Enfermedades Testiculares , Síndrome de Klinefelter , Quiste EpidérmicoRESUMEN
Orbital metastasis is an unusual localization within tumoral dissemination of prostatic cancer. Similarly, it is rare that orbital metastasis might be responsible for the clinic manifestations that determine the initial diagnosis of neoplasia. We illustrate the case of a patient suffering from prostatic adernocarcinoma that displayed alterations of facial sensitivity and right eye exophthalmos. We describe how the final diagnosis was reached and the patient's response to the suppressive hormonal treatment. The patient's rate of survival has proved to be longer than the rest of cases documented, with over 30-month follow-up.
Asunto(s)
Adenocarcinoma/secundario , Exoftalmia/etiología , Neoplasias Orbitales/secundario , Neoplasias de la Próstata/patología , Adenocarcinoma/diagnóstico por imagen , Anciano , Exoftalmia/diagnóstico por imagen , Exoftalmia/patología , Humanos , Imagen por Resonancia Magnética , Masculino , Neoplasias Orbitales/diagnóstico por imagen , Antígeno Prostático Específico/sangre , Neoplasias de la Próstata/sangre , Neoplasias de la Próstata/terapia , Tomografía Computarizada por Rayos XRESUMEN
Mucinous adenocarcinoma is a rare entity within the group of primary adenocarcinoma of the bladder which represent 0.5-2% of all malignant epithelial bladder tumours. In spite of the rarity of this tumoral type; it is a poor prognosis entity mainly due to its diagnosis especially in advanced stage of the disease. There is no general agreement on the treatment of adenocarcinoma of bladder. Not withstanding surgery would be the only curative treatment, although unfortunately, it is curative in just a few cases. We report six cases with mucinous adenocarcinoma of the bladder attended in our Department in the last ten years (january 1991-december 2001). In one of them a radical cystectomy was performed, while transurethral resection with or without adjuvant treatment was practiced in the other one. Only one patient is alive today, namely, the one where the tumour not invade the muscular tissue. These findings show the discouraging results of this entity closely intertwined with the pathologic stage.